A significant trend dominating the Lennox Gastaut Syndrome Market is the ongoing shift toward precision medicine, driven by the increasing recognition of the syndrome's genetic heterogeneity and the promise of targeted therapeutic interventions. Although LGS is defined by a constellation of clinical symptoms, the underlying etiology is often traced back to specific genetic mutations or early...